(Q43796533)

26 November 2017

Evaluation of a new hydroxyethyl starch solution (HES 130/0.4) in patients undergoing preoperative autologous blood donation (English)

1 reference

26 November 2017

Kasper SM

1

1 reference

26 November 2017

Strömich A

series ordinal

2

1 reference

26 November 2017

Kampe S

series ordinal

3

1 reference

26 November 2017

Radbruch L

series ordinal

4

1 reference

26 November 2017

1 November 2001

1 reference

Journal of Clinical Anesthesia

26 November 2017

1 reference

26 November 2017

13

1 reference

26 November 2017

7

1 reference

26 November 2017

486-490

1 reference

An international view of hydroxyethyl starches

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900311-7

7 January 2021

Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900311-7

7 January 2021

Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4)] after Single-Dose Infusion of 6% or 10% Solutions in Healthy Volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900311-7

7 January 2021

Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thrombelastography

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900311-7

7 January 2021

Volume therapy with a new hydroxyethyl starch solution in cardiac surgical patients before cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900311-7

7 January 2021

Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900311-7

7 January 2021

A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900311-7

7 January 2021

Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900311-7

7 January 2021

Autologous blood donation: hemodynamics in a high-risk patient population

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900311-7

7 January 2021

Lactated Ringer's solution versus hydroxyethyl starch for volume replacement in autologous blood donors with cardiovascular disease: a controlled, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900311-7

7 January 2021

Donor reactions and injuries from whole blood donation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900311-7

7 January 2021

Donation reactions among autologous donors

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900311-7

7 January 2021

[Hydroxyethyl starch accumulation in the skin with special reference to hydroxyethyl starch-associated pruritus]

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900311-7

7 January 2021

Giving long-persistent starch as volume replacement can cause pruritus after cardiac surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900311-7

7 January 2021

10.1016/S0952-8180(01)00311-7

Identifiers

DOI

1 reference

26 November 2017

1 reference